ERBB2 and breast carcinoma: The achievement of pathological complete response (pCR) after NAC predicts a good prognosis for HER-2 and TN breast cancers, but not for the luminal type because endocrine therapy affects the long-term outcomes of patients with HR-positive breast cancer (23, 24).